- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03097458
Enhancing Adjustment to Parental Cancer: Short-term Counselling for Families
Enhancing Adjustment to Parental Cancer: Short-term Counselling for Families. A Randomized, Wait-list Controlled Intervention Study
A parental cancer diagnosis challenges the family's stability and the parent-child relationship. It may impact the children's well-being, so that about one third of them develop clinically relevant levels of psychological distress. Psycho-oncological family-based counselling programs have been shown to elevate children's and parents' well-being. However, there is still a dearth of familial health services in Switzerland, which has also been recognized by the Swiss National Cancer Program (2011-2017).
This study aims to implement and evaluate a short-term family counselling intervention at the Cancer Center of the University Hospital Basel. The primary objective of the study is the enhancement of adjustment to the parental cancer diagnosis. The study seeks secondary to determine the feasibility of the short-term counselling Intervention.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Basel, Switzerland, 4031
- University Hospital Basel
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Informed Consent as documented by signature
- Diagnosis of any kind of cancer, inclusive relapse, within the last year with an expected survival of at least 8 months
- Married, cohabiting or single parent
- At least one child between 1-5 - 18 years
- German speaking
Exclusion Criteria:
- The diagnosis is more than 1 year ago
- Diagnosed patients (parent) not living with their children
- Diagnosed patients without custody of their children
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Counselling
short-term counselling for families
|
Counselling for Families which can take up to 6 weeks, with regular meetings under the guidance of a trained psychotherapist.
|
|
No Intervention: Wait-list control group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of children's quality of life on the health-related quality of life questionnaire (KINDL)
Time Frame: 6 weeks (change between baseline and week 6)
|
Enhancement of children's quality of life from T1 (baseline) to T2 (6 weeks) compared to the wait-list control group.
|
6 weeks (change between baseline and week 6)
|
|
Change of children's behavioral-emotional functioning on the Strengths and Difficulties Questionnaire (SDQ)
Time Frame: 6 weeks (change between baseline and week 6)
|
Enhancement of children's behavioral-emotional functioning from T1 (baseline) to T2 (6 weeks) compared to the wait-list control group.
|
6 weeks (change between baseline and week 6)
|
|
Change of parent's mental health on the Hospital Anxiety and Depression Scale (HADS)
Time Frame: 6 weeks (change between baseline and week 6)
|
Enhancement of parent's mental health from T1 (baseline) to T2 (6 weeks) compared to the wait-list control group.
|
6 weeks (change between baseline and week 6)
|
|
Change of family functioning on the Family Adaptability and Cohesion Evaluation Scale (FACES IV)
Time Frame: 6 weeks (change between baseline and week 6)
|
Enhancement of family functioning from T1 (baseline) to T2 (6 weeks) compared to the wait-list control group.
|
6 weeks (change between baseline and week 6)
|
|
Change of relationship quality on the relationship questionnaire (Partnerschaftsfragebogen PFB)
Time Frame: 6 weeks (change between baseline and week 6)
|
Enhancement of relationship quality from T1 (baseline) to T2 (6 weeks) compared to the wait-list control group.
|
6 weeks (change between baseline and week 6)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants willing to participate in the counselling
Time Frame: Through study completion, an average of 2 years
|
Secondary outcome will be to determine whether a short-term counselling intervention is feasible in the Swiss medical setting by collecting the number of participants willing to participate.
|
Through study completion, an average of 2 years
|
|
Sociodemographic characteristics (i.e. age, gender, education) of the participants willing to participate in the counselling with the sociodemographic questionnaire
Time Frame: Through study completion, an average of 2 years
|
Collecting sociodemographic characteristics of the population willing to participate with the sociodemographic questionnaire
|
Through study completion, an average of 2 years
|
|
Medical history characteristics (i.e. cancer diagnosis, cancer treatment) of the participants willing to participate in the counselling with the medical history questionnaire
Time Frame: Through study completion, an average of 2 years
|
Collecting medical history of the population willing to participate with the medical history questionnaire
|
Through study completion, an average of 2 years
|
|
Dropout rate during the recruitment and intervention procedure
Time Frame: Through study completion, an average of 2 years
|
Secondary outcome will be to determine whether a short-term counselling intervention is feasible in the Swiss medical setting by collecting dropout rate during the recruitment and intervention procedure.
|
Through study completion, an average of 2 years
|
|
Client satisfaction on the Client Satisfaction Questionnaire (CSQ-8)
Time Frame: Measures assessed after 6 weeks
|
German Version of the Client Satisfaction Questionnaire: Fragebogen zur Messung der Patientenzufriedenheit (ZUF-8) will be used to measure client's intervention satisfaction.
|
Measures assessed after 6 weeks
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- PP-16-07
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Palleon Pharmaceuticals, Inc.CompletedMelanoma | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Colon Cancer | Urothelial Cancer | Oncology | CRC | Esophagogastric Junction Cancer | EGJUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
University of California, San DiegoWithdrawnCervical Cancer | Cervical Cancer Stage | Cervical Cancer Stage IB2 | Cervical Cancer Stage IB1 | Cervical Cancer Stage I | Cervical Cancer Stage IB | Cervical Cancer Stage II | Cervical Cancer Stage IIa | Cervical Cancer, Stage IIB | Cervical Cancer, Stage III | Cervical Cancer Stage IIIB | Cervical Cancer... and other conditionsUnited States
Clinical Trials on Short-term Counselling for Families
-
University of TorontoRecruitingObesity Prevention | Metabolic Health | Dairy ConsumptionCanada
-
Yale UniversityNational Institute of Mental Health (NIMH)Not yet recruitingPregnancy | HIV | Pre-Exposure Prophylaxis of HIV InfectionUganda
-
Nova Scotia Health AuthorityCompletedSomatic Complaints of Multiple TypesCanada
-
University of MiamiRecruitingSpinal Cord Injuries | Peripheral Nerve InjuriesUnited States
-
Universidad de ValparaisoUniversity Diego PortalesRecruiting
-
Randi UlbergUniversity of OsloCompleted
-
UNEEG Medical A/SCompleted
-
Ben-Gurion University of the NegevSoroka University Medical Center; Soroka Hospital,Beer Sheva,IsraelRecruitingPTSD | Post Traumatic Stress DisorderIsrael
-
Sun Yat-sen UniversityUnknownMultifocal Contact LensesChina
-
Mental Health Services in the Capital Region, DenmarkUniversity of Copenhagen; Copenhagen Trial Unit, Center for Clinical Intervention...Completed